Viewing Study NCT00485732

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:43 PM
Ignite Modification Date: 2026-04-04 @ 8:20 PM
Study NCT ID: NCT00485732
Status: COMPLETED
Last Update Posted: 2018-07-20
First Post: 2007-06-12
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study to Evaluate the Immune Response and Safety of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine/Cervarix TM Vaccine in Healthy Females Aged 15-25 Years
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Infections, Papillomavirus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cervical neoplasia View
None AS04 View
None Randomized View
None Cervical cancer View
None HPV-16/18 L1 VLP AS04 View
None Phase IIIb View
None Korea View
None HPV View
None Double-blind View
None Controlled View